“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Alexion Pharmaceuticals Inc. (NASD: ALXN)? Today, we examine the outcome of a five year investment into the stock back in 2015.
| Start date: | 04/01/2015 |
|
|||
| End date: | 03/31/2020 | ||||
| Start price/share: | $169.50 | ||||
| End price/share: | $89.79 | ||||
| Starting shares: | 59.00 | ||||
| Ending shares: | 59.00 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | -47.03% | ||||
| Average annual return: | -11.93% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $5,296.50 | ||||
The above analysis shows the five year investment result worked out poorly, with an annualized rate of return of -11.93%. This would have turned a $10K investment made 5 years ago into $5,296.50 today (as of 03/31/2020). On a total return basis, that’s a result of -47.03% (something to think about: how might ALXN shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
Another great investment quote to think about:
“Ensure management’s interests are aligned with shareholders.” — Sam Zell
